National Guideline Clearinghouse | Topotecan for the treatment of recurrent and stage IVB cervical cancer.

National Institute for Health and Clinical Excellence (NICE).
Guideline Title
Topotecan for the treatment of recurrent and stage IVB cervical cancer.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Topotecan for the treatment of recurrent and stage IVB cervical cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Oct. 35 p. (Technology appraisal guidance; no. 183).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Topotecan for the treatment of recurrent and stage IVB cervical cancer.